The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Gustav Smith, MD, PhD

Gustav Smith

Associate professor

Gustav Smith, MD, PhD

CT-proAVP (copeptin), MR-proANP and Peroxiredoxin 4 after cardiac arrest: release profiles and correlation to outcome.

Author

  • Martin Annborn
  • Josef Dankiewicz
  • Niklas Nielsen
  • Malin Rundgren
  • Gustav Smith
  • S Hertel
  • J Struck
  • Hans Friberg

Summary, in English

Further characterization of the post-cardiac arrest syndrome (PCAS) is essential to better understand the mechanisms resulting in injury and death. We investigated serial serum concentrations of the stress hormone c-terminal provasopressin (CT-proAVP or copeptin), the cardiac biomarker MR-proANP and a biomarker of oxidation injury, Peroxiredoxin 4 (Prx4) in patients treated with mild hypothermia (MHT) after cardiac arrest, and studied their association to the PCAS and long-term outcome.

Department/s

  • Anesthesiology and Intensive Care
  • Cardiology
  • EXODIAB: Excellence of Diabetes Research in Sweden
  • EpiHealth: Epidemiology for Health

Publishing year

2014

Language

English

Pages

428-436

Publication/Series

Acta Anaesthesiologica Scandinavica

Volume

58

Issue

4

Document type

Journal article

Publisher

Wiley-Blackwell

Topic

  • Anesthesiology and Intensive Care

Status

Published

ISBN/ISSN/Other

  • ISSN: 0001-5172